Skip to content

Use of consumer smart wearable devices to detect early changes in physiological measures (heart rate, respirations and temperature) following vaccination before symptomatic onset of response to vaccine.

Consumer wearable devices and real-time detection of changes in physiological measures (heart rate, respirations and temperature) prior to onset of symptomatic reaction, post vaccination.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12624000208505
Enrollment
51
Registered
2024-03-01
Start date
2024-04-08
Completion date
2025-03-31
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Following the global COVID-19 pandemic, detecting viruses and infection symptomology has been important in minimising the spread of the infection but also to detect the early onset of infection in the body. This study focuses on using physiological measures, heart rate, respiration rate, sleep and temperature obtained from various non-invasive off the shelf consumer wearables (e.g., smart watches) to assist in potentially detecting the early signs of infections. Not only is this important to stop the spread of viral infections, but it could also provide insight in detecting the common cold or flu. As the spread of sicknesses can greatly affect people’s livelihood and productivity in various fields including but not exclusive to settings such as health care and the defence force, where work is 24/7 this study aims to use off the shelf consumer wearable devices (e.g., smart watch) to explore this.

Interventions

To accurately establish baseline physiological data for heart rate, respiration rate, and temperature, and to correctly detect changes in these physiological measures post vaccination, participants will be required to wear devices for 10 consecutive days prior to receiving their vaccination on day-11 and then for 3 consecutive days post vaccination. Participants will be required to book and receive a vaccination of their choosing e.g., seasonal flu, travel-based or COVID-19 booster shot on day-

To accurately establish baseline physiological data for heart rate, respiration rate, and temperature, and to correctly detect changes in these physiological measures post vaccination, participants will be required to wear devices for 10 consecutive days prior to receiving their vaccination on day-11 and then for 3 consecutive days post vaccination. Participants will be required to book and receive a vaccination of their choosing e.g., seasonal flu, travel-based or COVID-19 booster shot on day-11 of the study and then continue wearing the device for an additional 3-days. Devices being used in the study will be the Empatica Embraceplus, Garmin Venu SQ2 and the MotionWatch8. All are wrist worn devices and as such will be worn on participants wrists. Participants will be advised to wear devices at all times except for swimming, showering and charging. Device analytics for Empatica and Garmin devices will provide researchers with relative real time information to monitor adherence to the device wearing protocol.. Device analytics for MotionWatch8 will only be obtained once participants have returned the device and researchers download the data.

Sponsors

University of South Australia
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Participants must be between 18-years to 65-years of age Have booked to receive, no less than 10-days prior to collection of devices, an annual flu vaccination or COVID19 booster or travel vaccine. The vaccination must be administered by a registered health practitioner to participate in the study. Participants must have a normal body temperature between 36-37 degrees Celsius on the day the wearable devices are collected.

Exclusion criteria

Wrist or forearm tattoos located in the area where the wearable devices will be worn. Had no interstate or overseas travel in the prior 30 days Had symptoms of an acute respiratory infection in the prior 14 days: o cough o sore throat o fever or chills o runny nose o shortness of breath o loss of taste and smell. Contact in the last month with a person that had symptoms of an acute respiratory infection (including someone who has COVID19). Contact in the last 14-days with a suspected or confirmed COVID19 case Will not recruit o people 65 years and older with chronic medical conditions o people 70 years and older o people with chronic conditions or compromised immune systems o people in aged care facilities o people with a disability

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026